Association of Northern California Oncologists

http://www.anco.org/

 

ANCO’s ASCO Highlights 2019
H

ANCO's ASCO Update on HR+ Breast Cancer - Increased OS with Ribociclib/Endocrine Therapy & Improved PFS with Capivasertib + Fulvestrant

By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
461 views
September 12, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Breast
15:19
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update on HR+ Breast Cancer - Increased OS with Rib…

Feat. H. Chew
12:02
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Impr…

Feat. H. Chew